ADNAVANCE TECHNOLOGIES
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
ADNAVANCE TECHNOLOGIES
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2002-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.adnavance.com
Total Employee:
11+
Status:
Closed
Contact:
858-523-9250
Email Addresses:
[email protected]
Total Funding:
7.6 M USD
Technology used in webpage:
Font Awesome Nginx Powerline
Investors List
BDC Venture Capital
BDC Venture Capital investment in Series B - Adnavance Technologies
JovFunds
JovFunds investment in Series B - Adnavance Technologies
GrowthWorks Capital
GrowthWorks Capital investment in Series B - Adnavance Technologies
Business Development Bank of Canada
Business Development Bank of Canada investment in Series A - Adnavance Technologies
MDS Capital
MDS Capital investment in Series A - Adnavance Technologies
GrowthWorks Capital
GrowthWorks Capital investment in Series A - Adnavance Technologies
Official Site Inspections
http://www.adnavance.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
